Home › NDC Lookup › Labelers › Astellas Pharma Us, Inc.

Astellas Pharma Us, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 00469 (Astellas Pharma Us, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

37
Package NDCs
38
Products
38
Active listings
0
Discontinued
11
Ingredients
1
Therapeutic classes
12
Dosage forms
15
With NADAC pricing

Portfolio

By therapeutic class
CARDIOVASCULAR DIAGNOSTICS,NON-RAD... 1
Top ingredients
enzalutamide 10
Tacrolimus 6
isavuconazonium sulfate 4
mirabegron 4
ZOLBETUXIMAB 4
tacrolimus extended-release capsul... 3
fezolinetant 3
gilteritinib 1
amphotericin B 1
Micafungin sodium 1
By dosage form
TABLET 7
CAPSULE 6
INJECTION, POWDER, FOR SUSPENSION 4
INJECTION, POWDER, LYOPHILIZED, FO... 3
CAPSULE, GELATIN COATED 3
CAPSULE, COATED, EXTENDED RELEASE 3
TABLET, FILM COATED 3
POWDER 2

Browse records — 38 products

Drug / product Billing NDC NADAC / unit Status
AmBisome amphotericin B 50 mg/12.5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Astellas · NDC 00469-3051-30 · J0289 · 12.5 mL in 1 VIAL, SINGLE-DOSE (0469-3051-30) 00469-3051-30 — Discontinued View →
ASTAGRAF XL tacrolimus extended-release capsules 5 mg/1 CAPSULE, COATED, EXTENDED RELEASE Astellas · NDC 00469-0687-11 · 5 BLISTER PACK in 1 CARTON (0469-0687-11) / 10 CAPSULE, COATED, EXTENDED RELEASE in 1 BLISTER PACK 00469-0687-11 — Discontinued View →
ASTAGRAF XL tacrolimus extended-release capsules 1 mg/1 CAPSULE, COATED, EXTENDED RELEASE Astellas · NDC 00469-0677-11 · 5 BLISTER PACK in 1 CARTON (0469-0677-11) / 10 CAPSULE, COATED, EXTENDED RELEASE in 1 BLISTER PACK 00469-0677-11 — Discontinued View →
ASTAGRAF XL tacrolimus extended-release capsules .5 mg/1 CAPSULE, COATED, EXTENDED RELEASE Astellas · NDC 00469-0647-11 · 5 BLISTER PACK in 1 CARTON (0469-0647-11) / 10 CAPSULE, COATED, EXTENDED RELEASE in 1 BLISTER PACK 00469-0647-11 — Discontinued View →
CRESEMBA isavuconazonium sulfate 40 mg/1 CAPSULE Astellas · NDC 00469-2860-35 · 35 BLISTER PACK in 1 CARTON (0469-2860-35) / 1 CAPSULE in 1 BLISTER PACK 00469-2860-35 — On market View →
CRESEMBA isavuconazonium sulfate 100 mg/1 CAPSULE Astellas · NDC 00469-0520-14 · 4 CARTON in 1 CARTON (0469-0520-14) / 14 BLISTER PACK in 1 CARTON (0469-0520-02) / 1 CAPSULE in 1 BLISTER PACK 00469-0520-14 $107.124 /unit · NADAC On market View →
CRESEMBA isavuconazonium sulfate 40 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Astellas · NDC 00469-0420-99 · 10 CARTON in 1 CARTON (0469-0420-99) / 1 VIAL, SINGLE-DOSE in 1 CARTON (0469-0420-01) / 5 mL in 1 VIAL, SINGLE-DOSE 00469-0420-99 — On market View →
isavuconazonium sulfate .54 kg/kg POWDER Astellas · NDC 00469-1020-99 · 5 kg in 1 DRUM (0469-1020-99) 00469-1020-99 — On market View →
LEXISCAN regadenoson .08 mg/mL INJECTION, SOLUTION Astellas · NDC 00469-6501-89 · J2785 · 5 mL in 1 SYRINGE, PLASTIC (0469-6501-89) 00469-6501-89 — On market View →
mirabegron 1 kg/kg POWDER Astellas · NDC 00469-2603-01 · 20 kg in 1 DRUM (0469-2603-01) 00469-2603-01 — On market View →
Mycamine Micafungin sodium 10 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Astellas · NDC 00469-3250-10 · J2248 · 10 VIAL, SINGLE-DOSE in 1 CARTON (0469-3250-10) / 5 mL in 1 VIAL, SINGLE-DOSE 00469-3250-10 — On market View →
Myrbetriq mirabegron 50 mg/1 TABLET, FILM COATED, EXTENDED RELEASE Astellas · NDC 00469-2602-07 · 4 CARTON in 1 TRAY (0469-2602-07) / 1 BLISTER PACK in 1 CARTON / 7 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK 00469-2602-07 — On market View →
Myrbetriq mirabegron 8 mg/mL GRANULE, FOR SUSPENSION, EXTENDED RELEASE Astellas · NDC 00469-5020-99 · 1 BOTTLE in 1 CARTON (0469-5020-99) / 100 mL in 1 BOTTLE 00469-5020-99 $2.207 /unit · NADAC On market View →
Myrbetriq mirabegron 25 mg/1 TABLET, FILM COATED, EXTENDED RELEASE Astellas · NDC 00469-2601-07 · 4 CARTON in 1 TRAY (0469-2601-07) / 1 BLISTER PACK in 1 CARTON / 7 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK 00469-2601-07 — On market View →
Prograf Tacrolimus 5 mg/mL INJECTION, SOLUTION Astellas · NDC 00469-3016-01 · J7525 · 10 AMPULE in 1 BOX (0469-3016-01) / 1 mL in 1 AMPULE 00469-3016-01 — On market View →
Prograf Tacrolimus 1 mg/1 GRANULE, FOR SUSPENSION Astellas · NDC 00469-1330-50 · J7521 · 50 PACKET in 1 CARTON (0469-1330-50) / 1 GRANULE, FOR SUSPENSION in 1 PACKET 00469-1330-50 $7.445 /unit · NADAC On market View →
Prograf Tacrolimus .2 mg/1 GRANULE, FOR SUSPENSION Astellas · NDC 00469-1230-50 · J7521 · 50 PACKET in 1 CARTON (0469-1230-50) / 1 GRANULE, FOR SUSPENSION in 1 PACKET 00469-1230-50 $5.004 /unit · NADAC On market View →
Prograf Tacrolimus 5 mg/1 CAPSULE, GELATIN COATED Astellas · NDC 00469-0657-73 · J7507 · 1 BOTTLE in 1 CARTON (0469-0657-73) / 100 CAPSULE, GELATIN COATED in 1 BOTTLE 00469-0657-73 $35.634 /unit · NADAC On market View →
Prograf Tacrolimus .5 mg/1 CAPSULE, GELATIN COATED Astellas · NDC 00469-0607-73 · J7507 · 1 BOTTLE in 1 CARTON (0469-0607-73) / 100 CAPSULE, GELATIN COATED in 1 BOTTLE 00469-0607-73 $3.662 /unit · NADAC On market View →
Prograf Tacrolimus 1 mg/1 CAPSULE, GELATIN COATED Astellas · NDC 00469-0617-73 · J7507 · 1 BOTTLE in 1 CARTON (0469-0617-73) / 100 CAPSULE, GELATIN COATED in 1 BOTTLE 00469-0617-73 $7.315 /unit · NADAC On market View →
VEOZAH fezolinetant 45 mg/1 TABLET, FILM COATED Astellas · NDC 00469-2460-28 · 4 CARTON in 1 TRAY (0469-2460-28) / 1 BOTTLE in 1 CARTON (0469-2460-07) / 7 TABLET, FILM COATED in 1 BOTTLE 00469-2460-28 — On market View →
VEOZAH fezolinetant 45 mg/1 TABLET, FILM COATED Astellas · NDC 00469-2660-30 · 1 BOTTLE in 1 CARTON (0469-2660-30) / 30 TABLET, FILM COATED in 1 BOTTLE 00469-2660-30 $18.585 /unit · NADAC On market View →
VEOZAH fezolinetant 45 mg/1 TABLET, FILM COATED Astellas · NDC 00469-2760-28 · 4 CARTON in 1 TRAY (0469-2760-28) / 1 BLISTER PACK in 1 CARTON (0469-2760-07) / 7 TABLET, FILM COATED in 1 BLISTER PACK 00469-2760-28 — On market View →
VYLOY ZOLBETUXIMAB 20 mg/mL INJECTION, POWDER, FOR SUSPENSION Astellas · NDC 00469-3425-10 · J1326 · 1 VIAL in 1 BOX (0469-3425-10) / 5 mL in 1 VIAL 00469-3425-10 — On market View →
VYLOY ZOLBETUXIMAB 20 mg/mL INJECTION, POWDER, FOR SUSPENSION Astellas · NDC 00469-4425-30 · J1326 · 1 VIAL in 1 BOX (0469-4425-30) / 15 mL in 1 VIAL 00469-4425-30 — On market View →
VYLOY ZOLBETUXIMAB 20 mg/mL INJECTION, POWDER, FOR SUSPENSION Astellas · NDC 00469-4425-30 · J1326 · 1 VIAL in 1 BOX (0469-4425-30) / 15 mL in 1 VIAL 00469-4425-30 — On market View →
VYLOY ZOLBETUXIMAB 20 mg/mL INJECTION, POWDER, FOR SUSPENSION Astellas · NDC 00469-3425-10 · J1326 · 1 VIAL in 1 BOX (0469-3425-10) / 5 mL in 1 VIAL 00469-3425-10 — On market View →
Xospata gilteritinib 40 mg/1 TABLET Astellas · NDC 00469-1425-21 · 1 BOTTLE in 1 CARTON (0469-1425-21) / 21 TABLET in 1 BOTTLE 00469-1425-21 — On market View →
Xtandi enzalutamide 40 mg/1 TABLET Astellas · NDC 00469-0625-99 · 1 BOTTLE in 1 CARTON (0469-0625-99) / 120 TABLET in 1 BOTTLE 00469-0625-99 — On market View →
Xtandi enzalutamide 40 mg/1 CAPSULE Astellas · NDC 00469-0125-99 · 1 BOTTLE in 1 CARTON (0469-0125-99) / 120 CAPSULE in 1 BOTTLE 00469-0125-99 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.